Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Canetta

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Seminars in Oncology|February 1, 1990
Carboplatin in the first-line chemotherapy of ovarian cancerD S Alberts, R Canetta, N Mason-Liddil
Cancer Treatment Reviews|June 1, 1988
Carboplatin: current status and future prospectsR Canetta, K Bragman, L Smaldone, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1987
Non-Hodgkin's lymphomas in the elderly: prospective studies with specifically devised chemotherapy regimens in 66 patientsU Tirelli, A Carbone, V Zagonel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Current development of podophyllotoxinsR Canetta, P Hilgard, S Florentine, et al.
Seminars in Oncology|August 1, 1993
Current dosage and schedule issues in the development of paclitaxel (Taxol)S G Arbuck, R Canetta, N Onetto, et al.
Cancer Treatment Reviews|March 1, 1983
New platinum complexes in clinical trialsF H Lee, R Canetta, B F Issell, et al.
Oncology (Williston Park, N.Y.)|July 1, 1987
Clinical status of carboplatinR Canetta, C Franks, L Smaldone, et al.
Anti-Cancer Drugs|January 7, 1999
UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancerP M Hoff, R Pazdur, S E Benner, et al.
European Journal of Cancer|February 1, 1981
Estimation of differential in vitro sensitivity of non-Hodgkin lymphomas to anticancer drugsO Sanfilippo, M G Daidone, A Costa, et al.
Cancer Treatment Reviews|March 1, 1989
Megestrol acetate: clinical experienceL Schacter, M Rozencweig, R Canetta, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Seminars in Oncology|February 1, 1990
Carboplatin in the first-line chemotherapy of ovarian cancerD S Alberts, R Canetta, N Mason-Liddil
Cancer Treatment Reviews|June 1, 1988
Carboplatin: current status and future prospectsR Canetta, K Bragman, L Smaldone, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1987
Non-Hodgkin's lymphomas in the elderly: prospective studies with specifically devised chemotherapy regimens in 66 patientsU Tirelli, A Carbone, V Zagonel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Current development of podophyllotoxinsR Canetta, P Hilgard, S Florentine, et al.
Seminars in Oncology|August 1, 1993
Current dosage and schedule issues in the development of paclitaxel (Taxol)S G Arbuck, R Canetta, N Onetto, et al.
Cancer Treatment Reviews|March 1, 1983
New platinum complexes in clinical trialsF H Lee, R Canetta, B F Issell, et al.
Oncology (Williston Park, N.Y.)|July 1, 1987
Clinical status of carboplatinR Canetta, C Franks, L Smaldone, et al.
Anti-Cancer Drugs|January 7, 1999
UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancerP M Hoff, R Pazdur, S E Benner, et al.
European Journal of Cancer|February 1, 1981
Estimation of differential in vitro sensitivity of non-Hodgkin lymphomas to anticancer drugsO Sanfilippo, M G Daidone, A Costa, et al.
Cancer Treatment Reviews|March 1, 1989
Megestrol acetate: clinical experienceL Schacter, M Rozencweig, R Canetta, et al.
Pageof 4